35. Chin Clin Oncol. 2018 Jun;7(3):31. doi: 10.21037/cco.2018.06.05.Advances in treatment of metastatic breast cancer with bone metastasis.Wu Z(1), Lu J(2).Author information: (1)Department of Breast Surgery, Renji Hospital, School of Medicine, ShanghaiJiao Tong University, Shanghai 200127, China.(2)Department of Breast Surgery, Renji Hospital, School of Medicine, ShanghaiJiao Tong University, Shanghai 200127, China. lujjss@163.com.Bone is the most commonly seen metastatic site in all the metastatic breastcancer (MBC). Treatment includes systemic treatment according to differentmolecular subtypes and specified treatment of the bone. Bisphosphonate anddenosumab are the only two drugs approved to use in bone metastatic site. Theoptimal dosing schedule and duration of the drugs are still under research. Newdrugs and therapies including curcuminoids, sunitinib and nano particles arepotentially available in the near future.DOI: 10.21037/cco.2018.06.05 PMID: 30056733 